These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 11014584

  • 1. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA, Shappell SB.
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [Abstract] [Full Text] [Related]

  • 2. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ.
    Cancer Res; 2003 May 01; 63(9):2256-67. PubMed ID: 12727848
    [Abstract] [Full Text] [Related]

  • 3. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW.
    Cancer; 2002 Dec 15; 95(12):2487-93. PubMed ID: 12467061
    [Abstract] [Full Text] [Related]

  • 4. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J, Epstein JI.
    Am J Surg Pathol; 2009 Apr 15; 33(4):583-90. PubMed ID: 19033862
    [Abstract] [Full Text] [Related]

  • 5. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA, Shappell SB.
    J Urol; 2002 Aug 15; 168(2):519-24. PubMed ID: 12131301
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 15; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 7. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F, Epstein JI.
    Am J Surg Pathol; 2008 Jul 15; 32(7):1060-7. PubMed ID: 18496142
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L.
    Cancer; 2004 Jun 01; 100(11):2362-6. PubMed ID: 15160339
    [Abstract] [Full Text] [Related]

  • 9. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Myers RB, Schlom J, Srivastava S, Grizzle WE.
    Mod Pathol; 1995 Apr 01; 8(3):260-5. PubMed ID: 7617651
    [Abstract] [Full Text] [Related]

  • 10. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J, Bostwick DG.
    Exp Mol Pathol; 2004 Oct 01; 77(2):153-9. PubMed ID: 15351240
    [Abstract] [Full Text] [Related]

  • 11. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB, Magi-Galluzzi C, Han B, Zhou M.
    Am J Surg Pathol; 2010 Apr 01; 34(4):470-7. PubMed ID: 20182345
    [Abstract] [Full Text] [Related]

  • 12. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
    Shappell SB, Boeglin WE, Olson SJ, Kasper S, Brash AR.
    Am J Pathol; 1999 Jul 01; 155(1):235-45. PubMed ID: 10393855
    [Abstract] [Full Text] [Related]

  • 13. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I, McNeal JE, Ho SM, Jiang Z.
    Hum Pathol; 2003 Mar 01; 34(3):228-33. PubMed ID: 12673556
    [Abstract] [Full Text] [Related]

  • 14. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML.
    Clin Cancer Res; 1999 Dec 01; 5(12):4105-10. PubMed ID: 10632347
    [Abstract] [Full Text] [Related]

  • 15. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
    Altinok G, Powell IJ, Che M, Hormont K, Sarkar FH, Sakr WA, Grignon D, Liao DJ.
    Prostate Cancer Prostatic Dis; 2006 Dec 01; 9(1):77-82. PubMed ID: 16331298
    [Abstract] [Full Text] [Related]

  • 16. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN.
    Cancer Res; 2001 Jan 15; 61(2):497-503. PubMed ID: 11212240
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P, Amin MB, Xu HJ, Linden MD.
    Mod Pathol; 1998 Mar 15; 11(3):247-52. PubMed ID: 9521470
    [Abstract] [Full Text] [Related]

  • 18. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia.
    Patton KT, Chen HM, Joseph L, Yang XJ.
    Histopathology; 2005 Dec 15; 47(6):597-601. PubMed ID: 16324197
    [Abstract] [Full Text] [Related]

  • 19. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG, Qian J, Maihle NJ.
    Prostate; 2004 Feb 01; 58(2):164-8. PubMed ID: 14716741
    [Abstract] [Full Text] [Related]

  • 20. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Int J Oncol; 2004 Apr 01; 24(4):821-7. PubMed ID: 15010818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.